Speaker illustration

Doctor Till F Althoff

Hospital Clinic, University of Barcelona, Barcelona (Spain)

Member of:

European Society of Cardiology
European Heart Rythm Association

Dr. Althoff is senior consultant cardiologist and electrophysiologist at Hospital Clínic, University of Barcelona. Until 2020 he was Head of Cardiac Electrophysiology at the Department of Cardiology and Angiology, Charité University Hospital Berlin. His clinical and scientific work focuses on the personalized treatment of complex atrial and ventricular arrhythmias making use of novel imaging and non-invasive electroanatomical mapping techniques. He is also directing a translational research lab within the German Center for Cardiovascular Research (DZHK).

Standardized regionalization of the atria for 3D cardiac imaging, electroanatomical mapping and computational modeling. A multidisciplinary consensus of the PersonalizeAF consortium

Event: EHRA 2024

Topic: Diagnostic Methods

Session: Atrial fibrillation: clinical 2

Thumbnail

Non-invasive mapping of atrial slow-conduction areas and validation by endocardial isochronal mapping to predict atrial fibrillation recurrence after ablation

Event: EHRA 2024

Topic: Diagnostic Methods

Session: Atrial fibrillation: clinical 2

Thumbnail

Head-to-head comparison of pulsed field ablation, very high power-short duration, cryoballoon and conventional radiofrequency ablation by LGE-MRI-based ablation lesion assessment

Event: EHRA 2024

Topic: Rhythm Control, Catheter Ablation

Session: Atrial fibrillation: ablation 2

Thumbnail

Post-ablation atrial arrhythmogenic channels predict atrial fibrillation recurrence - iatrogenic substrate revisited

Event: EHRA 2024

Topic: Noninvasive Diagnostic Methods

Session: Arrhythmias 4

Thumbnail

Advanced practice nurse-coordinated same-day-discharge after atrial fibrillation ablation

Event: EHRA 2024

Topic: Rhythm Control, Catheter Ablation

Session: Atrial fibrillation: ablation 1

Thumbnail

Predictive value of late gadolinium enhancement MRI in patients with persistent atrial fibrillation. Multicentric validation of a standardised method

Event: ESC Congress 2022

Topic: Noninvasive Diagnostic Methods

Session: Prognosis and outcomes of various disease states

Thumbnail

Cardiac injury before and after COVID-19. A longitudinal MRI study

Event: ESC Congress 2022

Topic: Imaging

Session: Diagnostic methods in cardiac amyloidosis and other rare cardiomyopathies

Thumbnail

Non-invasive assessment of pulmonary vein isolation durability using late gadolinium enhancement MRI

Event: ESC Congress 2022

Topic: Noninvasive Diagnostic Methods

Session: From the atrium to the ventricle: progress in rhythm investigations and treatment

Thumbnail

Optimum timing to assess ablation lesions with Late Gadolinium Enhancement MRl

Event: EHRA 2021

Topic: Catheter Ablation of Arrhythmias

Session: Ablation in congenital heart disease and use of imaging techniques

Thumbnail

The biased angiotensin receptor 1-ligand TRV023 attenuates atherosclerosis through selective inhibition of Gq-mediated signaling

Event: ESC Congress 2019

Topic: Signal Transduction, Mechanotransduction

Session: Novel insights in atherosclerosis

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb